Evidence map›Paper›PMID 36682921›Full record

ArticleZeitschrift fur medizinische Physik2024

Machine learning-based approach reveals essential features for simplified TSPO PET quantification in ischemic stroke patients.

Artem Zatcepin, Anna Kopczak, Adrien Holzgreve, Sandra Hein, Andreas Schindler, Marco Duering, Lena Kaiser, Simon Lindner, Martin Schidlowski, Peter Bartenstein and 3 more

Open access · goldAbstract read
In one paragraph

Article in Zeitschrift fur medizinische Physik, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Artificial intelligence in medical physics.Zeitschrift fur medizinische Physik · 2024
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Artem ZatcepinDepartment of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany. Electronic address: artem.zatcepin@med.uni-muenchen.de.
Anna KopczakInstitute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.
Adrien HolzgreveDepartment of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Sandra HeinInstitute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany.
Andreas SchindlerDepartment of Neuroradiology, University Hospital, LMU Munich, Munich, Germany.
Marco DueringInstitute for Stroke and Dementia Research (ISD), University Hospital, LMU Munich, Munich, Germany; Medical Image Analysis Center (MIAC) & Department of Biomedical Engineering, University of Basel, Basel, Switzerland.
Lena KaiserDepartment of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Simon LindnerDepartment of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Martin SchidlowskiDepartment of Epileptology, University Hospital Bonn, Bonn, Germany; German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Peter BartensteinDepartment of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
Nathalie AlbertDepartment of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Matthias BrendelDepartment of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany; Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
Sibylle I ZieglerDepartment of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
LMU Klinikum · DELudwig-Maximilians-Universität München · DEMunich Cluster for Systems Neurology · DEUniversity Hospital Bonn · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionNeuroinflammation evaluation after acute ischemic stroke is a promising option for selecting an appropriate post-stroke treatment strategy. To assess neuroinflammation in vivo, translocator protein PET (TSPO PET) can be used. However, the gold standard TSPO PET quantification method includes a 90 min scan and continuous arterial blood sampling, which is challenging to perform on a routine basis. In this work, we determine what information is required for a simplified quantification approach using a machine learning algorithm. MATERIALS AND

methodsWe analyzed data from 18 patients with ischemic stroke who received 0-90 min [

resultsWhen using all the input features, the algorithm predicted V

conclusionReliable TSPO PET quantification is achievable by using a single late PET frame divided by a late blood sample activity concentration.

Indexed as

Ischemic StrokeMachine LearningPositron-Emission TomographyReceptors, GABAAgedAged, 80 and overCarbazolesFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedRadiopharmaceuticalsCarbazolesGE-180RadiopharmaceuticalsReceptors, GABATSPO protein, humanGE180Image-derived input functionIschemic strokeMachine learningQuantitative PETTSPO

Identifiers

PMID36682921
PMCPMC11156782
OpenAlexW4317780980

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.